SMT202400392T1 - Coniugato o il suo sale comprensivo di un antagonista del recettore del peptide di rilascio della gastrina e relativi usi - Google Patents
Coniugato o il suo sale comprensivo di un antagonista del recettore del peptide di rilascio della gastrina e relativi usiInfo
- Publication number
- SMT202400392T1 SMT202400392T1 SM20240392T SMT202400392T SMT202400392T1 SM T202400392 T1 SMT202400392 T1 SM T202400392T1 SM 20240392 T SM20240392 T SM 20240392T SM T202400392 T SMT202400392 T SM T202400392T SM T202400392 T1 SMT202400392 T1 SM T202400392T1
- Authority
- SM
- San Marino
- Prior art keywords
- gastrin
- conjugate
- salt
- receptor antagonist
- peptide receptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20306109.8A EP3973999A1 (en) | 2020-09-28 | 2020-09-28 | Conjugate or its salt comprising a gastrin-releasing peptide receptor antagonist and uses thereof |
| EP21778502.1A EP4188457B1 (en) | 2020-09-28 | 2021-09-22 | Conjugate or its salt comprising a gastrin-releasing peptide receptor antagonist and uses thereof |
| PCT/EP2021/076107 WO2022063850A1 (en) | 2020-09-28 | 2021-09-22 | Conjugate or its salt comprising a gastrin-releasing peptide receptor antagonist and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SMT202400392T1 true SMT202400392T1 (it) | 2024-11-15 |
Family
ID=74180915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SM20240392T SMT202400392T1 (it) | 2020-09-28 | 2021-09-22 | Coniugato o il suo sale comprensivo di un antagonista del recettore del peptide di rilascio della gastrina e relativi usi |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20230372552A1 (enExample) |
| EP (2) | EP3973999A1 (enExample) |
| JP (1) | JP7824281B2 (enExample) |
| KR (1) | KR20230078690A (enExample) |
| CN (1) | CN116322798A (enExample) |
| AU (1) | AU2021348219A1 (enExample) |
| BR (1) | BR112023003690A2 (enExample) |
| CA (1) | CA3189680A1 (enExample) |
| DK (1) | DK4188457T3 (enExample) |
| ES (1) | ES2989009T3 (enExample) |
| FI (1) | FI4188457T3 (enExample) |
| HR (1) | HRP20241285T1 (enExample) |
| HU (1) | HUE068360T2 (enExample) |
| IL (1) | IL300486A (enExample) |
| LT (1) | LT4188457T (enExample) |
| PL (1) | PL4188457T3 (enExample) |
| PT (1) | PT4188457T (enExample) |
| RS (1) | RS65994B1 (enExample) |
| SI (1) | SI4188457T1 (enExample) |
| SM (1) | SMT202400392T1 (enExample) |
| WO (1) | WO2022063850A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025163082A1 (en) | 2024-01-31 | 2025-08-07 | Molecular Partners Ag | Dll3-specific binding constructs and their use in radiotherapy |
| WO2026150109A1 (en) | 2025-01-10 | 2026-07-16 | Molecular Partners Ag | Mesothelin-specific binding constructs and their use in radiotherapy |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2100900A1 (en) | 2008-03-07 | 2009-09-16 | Universitätsspital Basel | Bombesin analog peptide antagonist conjugates |
| US20150217006A1 (en) * | 2014-02-06 | 2015-08-06 | Immunomedics, Inc. | Al-f-18-labeled, al-f-19-labeled and ga-68-labeled gastrin-releasing peptide receptor (grpr)-antagonists for imaging of prostate cancer |
| CA3050094C (en) | 2017-01-12 | 2024-01-02 | Radiomedix Inc. | Treatment of cancer cells overexpressing somatostatin receptors using ocreotide derivatives chelated to radioisotopes |
-
2020
- 2020-09-28 EP EP20306109.8A patent/EP3973999A1/en not_active Withdrawn
-
2021
- 2021-09-22 HR HRP20241285TT patent/HRP20241285T1/hr unknown
- 2021-09-22 PT PT217785021T patent/PT4188457T/pt unknown
- 2021-09-22 EP EP21778502.1A patent/EP4188457B1/en active Active
- 2021-09-22 ES ES21778502T patent/ES2989009T3/es active Active
- 2021-09-22 HU HUE21778502A patent/HUE068360T2/hu unknown
- 2021-09-22 KR KR1020237011366A patent/KR20230078690A/ko active Pending
- 2021-09-22 FI FIEP21778502.1T patent/FI4188457T3/fi active
- 2021-09-22 US US18/246,706 patent/US20230372552A1/en active Pending
- 2021-09-22 LT LTEPPCT/EP2021/076107T patent/LT4188457T/lt unknown
- 2021-09-22 BR BR112023003690A patent/BR112023003690A2/pt unknown
- 2021-09-22 RS RS20241053A patent/RS65994B1/sr unknown
- 2021-09-22 AU AU2021348219A patent/AU2021348219A1/en active Pending
- 2021-09-22 CA CA3189680A patent/CA3189680A1/en active Pending
- 2021-09-22 SM SM20240392T patent/SMT202400392T1/it unknown
- 2021-09-22 DK DK21778502.1T patent/DK4188457T3/da active
- 2021-09-22 JP JP2023518426A patent/JP7824281B2/ja active Active
- 2021-09-22 WO PCT/EP2021/076107 patent/WO2022063850A1/en not_active Ceased
- 2021-09-22 SI SI202130186T patent/SI4188457T1/sl unknown
- 2021-09-22 IL IL300486A patent/IL300486A/en unknown
- 2021-09-22 PL PL21778502.1T patent/PL4188457T3/pl unknown
- 2021-09-22 CN CN202180065166.XA patent/CN116322798A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4188457B1 (en) | 2024-07-03 |
| CN116322798A (zh) | 2023-06-23 |
| EP3973999A1 (en) | 2022-03-30 |
| EP4188457A1 (en) | 2023-06-07 |
| ES2989009T3 (es) | 2024-11-25 |
| JP7824281B2 (ja) | 2026-03-04 |
| PL4188457T3 (pl) | 2025-01-07 |
| AU2021348219A1 (en) | 2023-03-09 |
| WO2022063850A1 (en) | 2022-03-31 |
| LT4188457T (lt) | 2024-12-27 |
| SI4188457T1 (sl) | 2025-01-31 |
| HUE068360T2 (hu) | 2024-12-28 |
| JP2023542218A (ja) | 2023-10-05 |
| RS65994B1 (sr) | 2024-10-31 |
| BR112023003690A2 (pt) | 2023-04-04 |
| CA3189680A1 (en) | 2022-03-31 |
| DK4188457T3 (da) | 2024-08-26 |
| IL300486A (en) | 2023-04-01 |
| HRP20241285T1 (hr) | 2025-01-03 |
| US20230372552A1 (en) | 2023-11-23 |
| KR20230078690A (ko) | 2023-06-02 |
| FI4188457T3 (fi) | 2024-09-23 |
| PT4188457T (pt) | 2024-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI4188457T1 (sl) | Konjugat ali njegova sol, ki vsebuje antagonist peptidnega receptorja, ki sprošča gastrin, in njegova uporaba | |
| IL285148A (en) | Diligand drug conjugate and its use | |
| HUS2100003I1 (hu) | Angiotenzin receptor antagonista és NEP inhibitor gyógyszerészeti kombinációja | |
| IL288445B2 (en) | Annuloplasty and Tissue Anchor Technologies | |
| IL282312A (en) | Pharmaceutical preparations containing an ATR inhibitor and an antibody/drug pair that causes DNA alkylation and its use | |
| ZA200607241B (en) | Benzimidazole derivatives and use as a ii receptor antagonist | |
| MX2009009201A (es) | Composicion farmaceutica. | |
| IL177058A0 (en) | Polyheterocycilic compounds and their use as metabotropic glutamate receptor antagonists | |
| NL300768I2 (nl) | Combinatie van rilpivirine of een farmaceutisch aanvaardbaar zout van rilpivirine, waaronder het hydrochloridezout van rilpivirine, tenofovirdisoproxilfumaraat, en emtricitabine | |
| BRPI0917540A2 (pt) | composto, sal farmacologicamente aceitavél, composição farmacêutica, e, uso de um composto ou sal farmacologicamente aceitável | |
| IL201262A0 (en) | Gonadotropin-releasing hormone receptor antagonists and uses thereof | |
| EP2453923A4 (en) | PEPTIDE-ADMINISTRATED NON-COVALENT ADMINISTRATION OF ACTIVE AGENTS OVER THE BLOOD BRAIN BARRIERS | |
| SI1951661T1 (sl) | Antagonisti glukagonskega receptorja priprava interapevtske uporabe | |
| GB201911403D0 (en) | Conjugate and uses thereof | |
| PL1951658T3 (pl) | Antagoniści receptora glukagonu, preparatyka i zastosowania terapeutyczne | |
| PL3974441T3 (pl) | Związek peptydowy lub jego farmaceutycznie dopuszczalna sól | |
| EP3658348A4 (en) | 3D-PRINTED FRAMEWORK MADE OF PEPTIDE CONJUGATE POLYMER | |
| SG11202103791PA (en) | Nicotinic acetylcholine receptor peptide antagonist conotoxin compositions and related methods | |
| IL304703A (en) | gpr84 antagonists and their uses | |
| IL284805A (en) | Self-retaining anatomic dental barrier | |
| PL2252273T3 (pl) | Stała kompozycja farmaceutyczna zawierająca niepeptydowy związek antagonistyczny receptora angiotensyny II i środek moczopędny | |
| IL326963A (en) | LPAR1 antagonist and its use | |
| KR102474935B9 (ko) | 파에오놀 및 판테놀 또는 이들의 약학적으로 허용가능한 염을 유효성분으로 포함하는 약학적 조성물 | |
| WO2019074464A3 (en) | The pharmaceutical combination comprising dapoxetine and phosphodiesterase type-5 | |
| CY1105257T1 (el) | Χρηση των ανταγωνιστων των υποδοχεων της αγγειοτενσινης ii στην θepαπεια του οξεος εμφραγματος του μυοκαρδιου |